Free Trial

Blend Labs, Inc. (NYSE:BLND) Insider Sells $904,469.40 in Stock

Blend Labs logo with Computer and Technology background

Key Points

  • Nima Ghamsari, an insider at Blend Labs, Inc., sold 311,886 shares in a transaction valued at $904,469.40, resulting in a 5.14% decrease in their position.
  • Blend Labs reported a loss of ($0.03) EPS for the last quarter, missing the consensus estimate, along with revenues of $31.52 million which also fell short of expectations.
  • Analyst ratings for Blend Labs indicate a moderate buy stance, with target prices varying from $3.75 to $7.00, reflecting mixed market sentiments about the company's future performance.
  • Looking to export and analyze Blend Labs data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Blend Labs, Inc. (NYSE:BLND - Get Free Report) insider Nima Ghamsari sold 311,886 shares of Blend Labs stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $2.90, for a total value of $904,469.40. Following the sale, the insider owned 5,754,051 shares in the company, valued at $16,686,747.90. This trade represents a 5.14% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Nima Ghamsari also recently made the following trade(s):

  • On Friday, June 13th, Nima Ghamsari sold 75,720 shares of Blend Labs stock. The stock was sold at an average price of $3.30, for a total value of $249,876.00.
  • On Thursday, June 12th, Nima Ghamsari sold 44,130 shares of Blend Labs stock. The stock was sold at an average price of $3.52, for a total value of $155,337.60.

Blend Labs Price Performance

NYSE BLND traded up $0.21 on Monday, hitting $3.05. 3,273,319 shares of the company's stock were exchanged, compared to its average volume of 2,850,093. The firm's 50-day moving average price is $3.38 and its two-hundred day moving average price is $3.45. Blend Labs, Inc. has a fifty-two week low of $2.63 and a fifty-two week high of $5.53. The firm has a market cap of $791.96 million, a price-to-earnings ratio of -20.33 and a beta of 1.24.

Blend Labs (NYSE:BLND - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.05). The business had revenue of $31.52 million during the quarter, compared to the consensus estimate of $31.93 million. On average, research analysts predict that Blend Labs, Inc. will post -0.19 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently commented on BLND. Keefe, Bruyette & Woods cut their target price on Blend Labs from $4.00 to $3.75 and set a "market perform" rating on the stock in a research report on Friday, August 8th. Canaccord Genuity Group reaffirmed a "buy" rating and set a $5.25 price objective on shares of Blend Labs in a research note on Monday, May 12th. The Goldman Sachs Group decreased their price objective on Blend Labs from $5.60 to $4.80 and set a "buy" rating for the company in a research report on Monday, May 12th. JMP Securities restated a "market outperform" rating and set a $7.00 price target on shares of Blend Labs in a research note on Wednesday, May 28th. Finally, Wall Street Zen raised Blend Labs from a "sell" rating to a "hold" rating in a report on Sunday. Three equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Blend Labs has an average rating of "Moderate Buy" and an average price target of $4.88.

Check Out Our Latest Report on Blend Labs

Hedge Funds Weigh In On Blend Labs

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Revolve Wealth Partners LLC purchased a new stake in shares of Blend Labs in the 4th quarter worth about $132,000. Geode Capital Management LLC lifted its position in shares of Blend Labs by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 4,842,483 shares of the company's stock valued at $20,391,000 after acquiring an additional 75,379 shares in the last quarter. Wells Fargo & Company MN raised its holdings in Blend Labs by 49.7% in the 4th quarter. Wells Fargo & Company MN now owns 121,206 shares of the company's stock valued at $510,000 after acquiring an additional 40,266 shares during the last quarter. Invesco Ltd. lifted its stake in shares of Blend Labs by 1,230.9% during the 4th quarter. Invesco Ltd. now owns 1,576,347 shares of the company's stock worth $6,636,000 after purchasing an additional 1,457,901 shares during the period. Finally, Raymond James Financial Inc. purchased a new position in shares of Blend Labs during the 4th quarter worth $2,864,000. Institutional investors and hedge funds own 52.56% of the company's stock.

About Blend Labs

(Get Free Report)

Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.

Further Reading

Insider Buying and Selling by Quarter for Blend Labs (NYSE:BLND)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Blend Labs Right Now?

Before you consider Blend Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blend Labs wasn't on the list.

While Blend Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW
Strong Earnings? Market Says NVIDIA-Level Growth or Be Forgotten

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines